Cargando…
EGFR-TKIs治疗非小细胞肺癌EGFR罕见突变的研究进展
Lung cancer is the most common cancer and the leading cause of cancer death. Non-small cell lung cancer (NSCLC) represents over 85% of all lung cancers, and up to 50% of Asian NSCLC patients harboring epidermal growth factor receptor (EGFR) gene mutations. A number of studies have consistently demon...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754574/ https://www.ncbi.nlm.nih.gov/pubmed/31526464 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.09.07 |